New player Aegros coming into the plasma market late in 2023 with 1ML facility in 2025, could be positive for CSL as this new technology increases yeilds, if CSL would like to license their tech, it would could improve revenues 1-2B p/a for CSL.
- Forums
- Charts
- CSL Chart
New player Aegros coming into the plasma market late in 2023...
-
- There are more pages in this discussion • 306 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$275.50 |
Change
-0.300(0.11%) |
Mkt cap ! $133.1B |
Open | High | Low | Value | Volume |
$276.76 | $277.00 | $275.36 | $128.2M | 465.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100 | $275.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$275.68 | 189 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100 | 275.300 |
2 | 1040 | 275.100 |
11 | 2892 | 275.000 |
1 | 3 | 274.950 |
1 | 1020 | 274.940 |
Price($) | Vol. | No. |
---|---|---|
275.680 | 189 | 1 |
275.750 | 562 | 1 |
275.830 | 447 | 1 |
275.850 | 5000 | 1 |
275.980 | 1020 | 1 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
$275.43 |
  |
Change
-0.300 ( 0.30 %) |
|||
Open | High | Low | Volume | ||
$276.39 | $277.00 | $275.39 | 183080 | ||
Last updated 15.59pm 06/05/2024 ? |
Featured News
CSL (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online